Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Niesvizky

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cancer Investigation|January 1, 1997
Pathophysiology and management of bone disease in multiple myelomaR Niesvizky, R P Warrell
Blood Reviews|March 1, 1993
Biology and treatment of multiple myelomaR Niesvizky, D Siegel, J Michaeli
Blood|February 1, 1993
2-Chlorodeoxyadenosine for multiple myelomaR Niesvizky, D Siegel, J Michaeli
The New England Journal of Medicine|July 3, 1999
Epstein-Barr virus-associated lymphoma after treatment of macroglobulinemia with cladribineR Niesvizky, A X Zhu, D Louie, et al.
The American Journal of Pathology|October 1, 1992
Proto-oncogene analysis in multiple myelomaM Ladanyi, S Wang, R Niesvizky, et al.
Leukemia|November 23, 2007
Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patientsA Mazumder, J Kaufman, R Niesvizky, et al.
Blood|August 1, 1995
Proteinaceous (angiocentric sclerosing) lymphadenopathy: a polyclonal systemic, nonamyloid deposition disorderJ Michaeli, R Niesvizky, D Siegel, et al.
Leukemia|December 22, 1999
Extensive bone marrow necrosis associated with multiple myelomaA X Zhu, R Niesvizky, E Hedrick, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1994
von Willebrand factor binding to collagen in patients with end-stage renal diseaseR Niesvizky, C Calandri, N D Patel, et al.
British Journal of Haematology|January 1, 1995
Hypercalcaemia and increased serum interleukin-6 levels induced by all-trans retinoic acid in patients with multiple myelomaR Niesvizky, D S Siegel, X Busquets, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cancer Investigation|January 1, 1997
Pathophysiology and management of bone disease in multiple myelomaR Niesvizky, R P Warrell
Blood Reviews|March 1, 1993
Biology and treatment of multiple myelomaR Niesvizky, D Siegel, J Michaeli
Blood|February 1, 1993
2-Chlorodeoxyadenosine for multiple myelomaR Niesvizky, D Siegel, J Michaeli
The New England Journal of Medicine|July 3, 1999
Epstein-Barr virus-associated lymphoma after treatment of macroglobulinemia with cladribineR Niesvizky, A X Zhu, D Louie, et al.
The American Journal of Pathology|October 1, 1992
Proto-oncogene analysis in multiple myelomaM Ladanyi, S Wang, R Niesvizky, et al.
Leukemia|November 23, 2007
Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patientsA Mazumder, J Kaufman, R Niesvizky, et al.
Blood|August 1, 1995
Proteinaceous (angiocentric sclerosing) lymphadenopathy: a polyclonal systemic, nonamyloid deposition disorderJ Michaeli, R Niesvizky, D Siegel, et al.
Leukemia|December 22, 1999
Extensive bone marrow necrosis associated with multiple myelomaA X Zhu, R Niesvizky, E Hedrick, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1994
von Willebrand factor binding to collagen in patients with end-stage renal diseaseR Niesvizky, C Calandri, N D Patel, et al.
British Journal of Haematology|January 1, 1995
Hypercalcaemia and increased serum interleukin-6 levels induced by all-trans retinoic acid in patients with multiple myelomaR Niesvizky, D S Siegel, X Busquets, et al.
Pageof 3